160 related articles for article (PubMed ID: 27406249)
1. Novel microdeletions on chromosome 14q32.2 suggest a potential role for non-coding RNAs in Kagami-Ogata syndrome.
van der Werf IM; Buiting K; Czeschik C; Reyniers E; Vandeweyer G; Vanhaesebrouck P; Lüdecke HJ; Wieczorek D; Horsthemke B; Mortier G; Leroy JG; Kooy RF
Eur J Hum Genet; 2016 Dec; 24(12):1724-1729. PubMed ID: 27406249
[TBL] [Abstract][Full Text] [Related]
2. Kagami-Ogata syndrome: a clinically recognizable upd(14)pat and related disorder affecting the chromosome 14q32.2 imprinted region.
Ogata T; Kagami M
J Hum Genet; 2016 Feb; 61(2):87-94. PubMed ID: 26377239
[TBL] [Abstract][Full Text] [Related]
3. Maternally inherited deletion encompassing the RTL1as and MEG8 genes of the human 14q32 imprinted region in a patient with a mild Kagami-Ogata syndrome phenotype.
Sirera Sirera P; García-Payá E; Olivas García J; Jadraque Rodríguez R; Hernández Romero SD
Am J Med Genet A; 2023 Aug; 191(8):2225-2231. PubMed ID: 37222159
[TBL] [Abstract][Full Text] [Related]
4. Two infants with mild, atypical clinical features of Kagami-Ogata syndrome caused by epimutation.
Higashiyama H; Ohsone Y; Takatani R; Futatani T; Kosaki R; Kagami M
Eur J Med Genet; 2022 Oct; 65(10):104580. PubMed ID: 35953028
[TBL] [Abstract][Full Text] [Related]
5. Paternal uniparental disomy chromosome 14-like syndrome due a maternal de novo 160 kb deletion at the 14q32.2 region not encompassing the IG- and the MEG3-DMRs: Patient report and genotype-phenotype correlation.
Corsello G; Salzano E; Vecchio D; Antona V; Grasso M; Malacarne M; Carella M; Palumbo P; Piro E; Giuffrè M
Am J Med Genet A; 2015 Dec; 167A(12):3130-8. PubMed ID: 26333487
[TBL] [Abstract][Full Text] [Related]
6. New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome.
Beygo J; Küchler A; Gillessen-Kaesbach G; Albrecht B; Eckle J; Eggermann T; Gellhaus A; Kanber D; Kordaß U; Lüdecke HJ; Purmann S; Rossier E; van de Nes J; van der Werf IM; Wenzel M; Wieczorek D; Horsthemke B; Buiting K
Eur J Hum Genet; 2017 Aug; 25(8):935-945. PubMed ID: 28635951
[TBL] [Abstract][Full Text] [Related]
7. Kagami-Ogata syndrome in a patient with 46,XX,t(2;14)(q11.2;q32.2)mat disrupting MEG3.
Omark J; Masunaga Y; Hannibal M; Shaw B; Fukami M; Kato F; Saitsu H; Kagami M; Ogata T
J Hum Genet; 2021 Apr; 66(4):439-443. PubMed ID: 33067531
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diagnosis of Kagami-Ogata syndrome.
Molinet Coll C; Sabrià Bach J; Izquierdo Renau M; Alarcón Allen A; Monk D; Gómez Del Rincón O; Milà Recasens M; Martínez Crespo JM
J Clin Ultrasound; 2021 Jun; 49(5):498-501. PubMed ID: 33179779
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of coat-hanger ribs detected on three-dimensional ultrasound for prenatal diagnosis of Kagami-Ogata syndrome.
Kuriki A; Hosoya S; Ozawa K; Wada S; Kosugi Y; Wada YS; Sekizawa A; Miyazaki O; Kagami M; Sago H
J Obstet Gynaecol Res; 2022 Dec; 48(12):3314-3318. PubMed ID: 36087043
[TBL] [Abstract][Full Text] [Related]
10. [Kagami-Ogata Syndrome: An Anomaly of the Ribs as a Pathognomonic Feature for the Clinical Diagnosis of an (epi)Genetic Syndrome].
Westeppe S; Dionysopoulou A; Kidszun A; Schmeh I; Bartsch O; Mildenberger E; Winter J
Z Geburtshilfe Neonatol; 2020 Jun; 224(3):153-159. PubMed ID: 31853915
[TBL] [Abstract][Full Text] [Related]
11. Novel deletions affecting the MEG3-DMR provide further evidence for a hierarchical regulation of imprinting in 14q32.
Beygo J; Elbracht M; de Groot K; Begemann M; Kanber D; Platzer K; Gillessen-Kaesbach G; Vierzig A; Green A; Heller R; Buiting K; Eggermann T
Eur J Hum Genet; 2015 Feb; 23(2):180-8. PubMed ID: 24801763
[TBL] [Abstract][Full Text] [Related]
12. Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell Syndrome-compatible phenotype.
Kagami M; Mizuno S; Matsubara K; Nakabayashi K; Sano S; Fuke T; Fukami M; Ogata T
Eur J Hum Genet; 2015 Aug; 23(8):1062-7. PubMed ID: 25351781
[TBL] [Abstract][Full Text] [Related]
13. Kagami-Ogata syndrome: an important differential diagnosis to Beckwith-Wiedemann syndrome.
Altmann J; Horn D; Korinth D; Eggermann T; Henrich W; Verlohren S
J Clin Ultrasound; 2020 May; 48(4):240-243. PubMed ID: 31994200
[TBL] [Abstract][Full Text] [Related]
14. Novel 14q32.2 paternal deletion encompassing the whole DLK1 gene associated with Temple syndrome.
Baena N; Monk D; Aguilera C; Fraga MF; Fernández AF; Gabau E; Corripio R; Capdevila N; Trujillo JP; Ruiz A; Guitart M
Clin Epigenetics; 2024 May; 16(1):62. PubMed ID: 38715103
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive clinical studies in 34 patients with molecularly defined UPD(14)pat and related conditions (Kagami-Ogata syndrome).
Kagami M; Kurosawa K; Miyazaki O; Ishino F; Matsuoka K; Ogata T
Eur J Hum Genet; 2015 Nov; 23(11):1488-98. PubMed ID: 25689926
[TBL] [Abstract][Full Text] [Related]
16. Temple syndrome and Kagami-Ogata syndrome: clinical presentations, genotypes, models and mechanisms.
Prasasya R; Grotheer KV; Siracusa LD; Bartolomei MS
Hum Mol Genet; 2020 Sep; 29(R1):R107-R116. PubMed ID: 32592473
[TBL] [Abstract][Full Text] [Related]
17. Maternally inherited 133kb deletion of 14q32 causing Kagami-Ogata syndrome.
Jung HS; Vallee SE; Dinulos MB; Tsongalis GJ; Lefferts JA
J Hum Genet; 2018 Dec; 63(12):1231-1239. PubMed ID: 30232357
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide multilocus imprinting disturbance analysis in Temple syndrome and Kagami-Ogata syndrome.
Kagami M; Matsubara K; Nakabayashi K; Nakamura A; Sano S; Okamura K; Hata K; Fukami M; Ogata T
Genet Med; 2017 Apr; 19(4):476-482. PubMed ID: 27632690
[TBL] [Abstract][Full Text] [Related]
19. Preimplantation genetic testing for a chr14q32 microdeletion in a family with Kagami-Ogata syndrome and Temple syndrome.
Sabria-Back J; Monteagudo-Sánchez A; Sánchez-Delgado M; Ferguson-Smith AC; Gómez O; Pertierra Cartada A; Tenorio J; Nevado J; Lapunzina P; Pereda Aguirre A; Giménez Sevilla C; Toro Toro E; Perez de Nanclares G; Monk D
J Med Genet; 2022 Mar; 59(3):253-261. PubMed ID: 33579810
[TBL] [Abstract][Full Text] [Related]
20. Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR.
Kagami M; Yanagisawa A; Ota M; Matsuoka K; Nakamura A; Matsubara K; Nakabayashi K; Takada S; Fukami M; Ogata T
Clin Epigenetics; 2019 Mar; 11(1):42. PubMed ID: 30846001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
